NCT01678027View on ClinicalTrials.gov

Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,838

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2035

Conditions
Gastric CancerHelicobacter Pylori InfectionFamily Members
Interventions
DRUG

Placebo

Lansoprazole placebo, amoxicillin placebo, and clarithromycin placebo, all twice a day for 1 week.

DRUG

LAC triple therapy

Lansoprazole 30 mg, amoxicillin 1,000 mg, and clarithromycin 500 mg, all twice a day for 1 week.

Trial Locations (1)

10408

National Cancer Center, Korea, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV